Sales 2022 | 10.48M 14.31M | Sales 2023 | 9.44M 12.89M | Capitalization | 1.89M 2.57M |
---|---|---|---|---|---|
Net income 2022 | -11M -15.01M | Net income 2023 | -18M -24.56M | EV / Sales 2022 | 0.97 x |
Net Debt 2022 | 6.89M 9.4M | Net Debt 2023 | 9.28M 12.67M | EV / Sales 2023 | 1.18 x |
P/E ratio 2022 |
-0.16
x | P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.17% |
Latest transcript on Cesca Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Xiao Chun Xu
CEO | Chief Executive Officer | 53 | 16-03-09 |
Jeffery Cauble
DFI | Director of Finance/CFO | 51 | 09-12-31 |
Wendy Samford
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Chun Xu
CEO | Chief Executive Officer | 53 | 16-03-09 |
Biao Xi
BRD | Director/Board Member | - | 23-07-13 |
1st Jan change | Capi. | |
---|---|---|
-11.18% | 4.33B | |
+2.31% | 3.21B | |
+16.32% | 2.26B | |
+10.75% | 1.01B | |
+8.93% | 946M | |
-41.40% | 890M | |
-59.03% | 645M | |
-35.65% | 629M | |
-29.46% | 626M |